remission at transplantation in adults with high-risk acute leukemia : a risk factor analysis of A survey of fully haploidentical hematopoietic stem cell transplantation

Polge, Francesco Frassoni, Massimo F. Martelli and Vanderson Rocha Arnon Nagler, Paolo Di Bartolomeo, João F. Lacerda, Maria Teresa Lupo Stanghellini, Emmanuelle Fabio Ciceri, Myriam Labopin, Franco Aversa, Jakob M. Rowe, Donald Bunjes, Philippe Lewalle, outcomes for patients in remission at transplantation in adults with high-risk acute leukemia: a risk factor analysis of A survey of fully haploidentical hematopoietic stem cell transplantation

[1]  A. Gratwohl,et al.  Results of the EBMT activity survey 2005 on haematopoietic stem cell transplantation: focus on increasing use of unrelated donors , 2007, Bone Marrow Transplantation.

[2]  L. Kanz,et al.  Haploidentical allogeneic hematopoietic cell transplantation in adults with reduced-intensity conditioning and CD3/CD19 depletion: fast engraftment and low toxicity. , 2006, Experimental hematology.

[3]  T. Spitzer,et al.  Current status of haploidentical stem cell transplantation , 2006, British journal of haematology.

[4]  W. Hiddemann,et al.  Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation. , 2006, Blood.

[5]  N. Schmitz,et al.  Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe , 2002, Bone Marrow Transplantation.

[6]  P. Ljungman,et al.  Risk factors for the development of cytomegalovirus disease after allogeneic stem cell transplantation. , 2006, Haematologica.

[7]  A. Tosti,et al.  Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation. , 2005, Blood.

[8]  A. Cometa,et al.  Human mesenchymal stem cells and cyclosporin a exert a synergistic suppressive effect on in vitro activation of alloantigen-specific cytotoxic lymphocytes. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[9]  E. Hauben,et al.  Regulatory T cells: prospective for clinical application in hematopoietic stem cell transplantation , 2005, Current opinion in hematology.

[10]  A. Fischer,et al.  Improving immune reconstitution while preventing GvHD in allogeneic stem cell transplantation. , 2005, Cytotherapy.

[11]  J. Wagner,et al.  Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. , 2004, The New England journal of medicine.

[12]  M. Labopin,et al.  Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. , 2004, The New England journal of medicine.

[13]  M. Labopin,et al.  Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: influence of dose and stem cell source shows better outcome with rich marrow. , 2003, Blood.

[14]  F. Claas,et al.  Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling. , 2002, Blood.

[15]  F. Aversa.  Full haplotype mismatched hematopoietic stem cell transplants. , 2002, Haematologica.

[16]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .

[17]  J Crowley,et al.  Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. , 1999, Statistics in medicine.

[18]  M. Martelli,et al.  Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. , 1998, The New England journal of medicine.

[19]  K. Sullivan,et al.  Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. , 1980, The American journal of medicine.

[20]  P. Neiman,et al.  CLINICAL MANIFESTATIONS OF GRAFT‐VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL‐A-MATCHED SIBLING DONOR,S , 1974, Transplantation.